Inclusion Criteria : 
  -  Patients with uni - or bipolar depression , diagnosed according to the criteria of the DSM - IV via MINI 6.0 diagnostic tool . 
  -  At the time of inclusion in the study , the symptoms must meet at least the requirements of a moderately severe depression , defined by a minimum score of ≥ 22 on the Montgomery - Åsberg Depression Scale . 
Exclusion Criteria : 
  -  Patients with severe somatic , rheumatic , endocrine or neurological comorbidities.  This includes in particular neurological disorders associated with cognitive disorder , severe liver , kidney and cardiac diseases . 
  -  Patients , who are being treated permanently with anti - inflammatory or immunosuppressive drugs ( e. g.  corticosteroids or alpha / beta - a ( nta ) gonists , immuno suppressant drugs )  . 
  -  Patients with severe psychiatric disorders ( Axis I ) such as schizophrenia , dementia , ADHD , obsessive - compulsive disorder , current alcohol , drugs or drug addiction . 
  -  Patients who have already been treated unsuccessfully with sertraline and all alternate medications allowed in the study . 
  -  Pregnant or lactating ( breast feeding ) women.